Omega Funds
Venture capital · Boston, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
14Deep-tech portfolio2 active
11Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: EnLiven Therapeutics
57Co-investorsShare a portfolio company
Portfolio · 14 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| ARTBIO | Biotech | Active | — | — |
| Invaio Sciences | Agritech | Active | — | — |
| EnLiven Therapeutics | Biotech | Public | Apr 3, 2024 | $140.1M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Abata Therapeutics | Biotech | Closed | Dec 27, 2023 | $60.3M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Keros Therapeutics | Biotech | Public | Mar 12, 2020 | $70.8M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
| Magenta Therapeutics | Biotech | Acquired | Apr 9, 2018 | $116.0M |
| Scholar Rock | Biotech | Public | Jan 4, 2016 | $36.3M |
| Karuna Therapeutics | Biotech | Acquired | — | — |
| Omega Therapeutics | Biotech | Acquired | — | — |
| Praxis Precision Medicine | Biotech | Public | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#33
Portfolio exits#8
Raises, 12 months#88
Co-investors#20
Co-investors
- Third Rock VenturesVenture capital6 shared
- Gurnet Point CapitalVenture capital4 shared
- Biotechnology Value FundVenture capital3 shared
- Brookside CapitalVenture capital3 shared
- Deerfield Capital ManagementVenture capital3 shared
- EcoR1 CapitalVenture capital3 shared
- Mission Bay CapitalVenture capital3 shared
- The Column GroupVenture capital3 shared
- Alexandria Venture InvestmentsVenture capital2 shared
- Astellas Venture ManagementVenture capital2 shared
Sectors
- Biotech13
- Agritech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.